Nuo Therapeutics, Inc. (AURX)
USD 1.35
(-1.46%)
USD 1.35
(-1.46%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 608.52 Thousand USD | 442.12% |
| 2022 | 112.25 Thousand USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | -100.0% |
| 2019 | 146.17 Thousand USD | -89.33% |
| 2018 | 1.37 Million USD | 90.08% |
| 2017 | 721.04 Thousand USD | -67.29% |
| 2016 | 2.2 Million USD | -80.85% |
| 2015 | 11.51 Million USD | 48.3% |
| 2014 | 7.76 Million USD | -32.92% |
| 2013 | 11.57 Million USD | 9.53% |
| 2012 | 10.56 Million USD | 45.77% |
| 2011 | 7.24 Million USD | 85.31% |
| 2010 | 3.91 Million USD | 89.29% |
| 2009 | 2.06 Million USD | -1.17% |
| 2008 | 2.09 Million USD | 7.59% |
| 2007 | 1.94 Million USD | -0.25% |
| 2006 | 1.94 Million USD | 28.64% |
| 2005 | 1.51 Million USD | 32.2% |
| 2004 | 1.14 Million USD | 5.4% |
| 2003 | 1.08 Million USD | 171.43% |
| 2002 | 400.44 Thousand USD | 838.11% |
| 2001 | 42.68 Thousand USD | -86.61% |
| 2000 | 318.81 Thousand USD | 3607.2% |
| 1999 | 8600.00 USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 234.57 Thousand USD | 19.07% |
| 2024 Q2 | 364.77 Thousand USD | 55.5% |
| 2023 FY | 608.52 Thousand USD | 442.12% |
| 2023 Q2 | 118.16 Thousand USD | 93.4% |
| 2023 Q1 | 61.1 Thousand USD | -17.43% |
| 2023 Q3 | 232.24 Thousand USD | 96.53% |
| 2023 Q4 | 197.01 Thousand USD | -15.17% |
| 2022 Q1 | - USD | 0.0% |
| 2022 FY | 112.25 Thousand USD | 0.0% |
| 2022 Q4 | 74 Thousand USD | 93.46% |
| 2022 Q3 | 38.25 Thousand USD | 0.0% |
| 2022 Q2 | - USD | 0.0% |
| 2021 Q2 | - USD | 0.0% |
| 2021 Q1 | - USD | 0.0% |
| 2021 Q4 | - USD | 0.0% |
| 2021 Q3 | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2020 FY | - USD | -100.0% |
| 2020 Q3 | - USD | 0.0% |
| 2020 Q4 | - USD | 0.0% |
| 2019 FY | 146.17 Thousand USD | -89.33% |
| 2019 Q2 | 44.16 Thousand USD | 12.58% |
| 2019 Q3 | 57.88 Thousand USD | 31.06% |
| 2019 Q4 | 4900.00 USD | -91.53% |
| 2019 Q1 | 39.22 Thousand USD | -95.17% |
| 2018 Q4 | 812.06 Thousand USD | 212.0% |
| 2018 FY | 1.37 Million USD | 90.08% |
| 2018 Q1 | 159.94 Thousand USD | -19.02% |
| 2018 Q3 | 260.28 Thousand USD | 88.19% |
| 2018 Q2 | 138.3 Thousand USD | -13.53% |
| 2017 Q3 | 162.19 Thousand USD | -14.0% |
| 2017 FY | 721.04 Thousand USD | -67.29% |
| 2017 Q1 | 172.74 Thousand USD | 7.42% |
| 2017 Q2 | 188.6 Thousand USD | 9.18% |
| 2017 Q4 | 197.5 Thousand USD | 21.77% |
| 2016 Q3 | 176.77 Thousand USD | -61.46% |
| 2016 Q1 | 1.4 Million USD | -12.49% |
| 2016 Q2 | 458.72 Thousand USD | -67.43% |
| 2016 FY | 2.2 Million USD | -80.85% |
| 2016 Q4 | 160.81 Thousand USD | -9.03% |
| 2015 FY | 11.51 Million USD | 48.3% |
| 2015 Q4 | 1.6 Million USD | -25.81% |
| 2015 Q3 | 2.16 Million USD | -25.08% |
| 2015 Q2 | 2.89 Million USD | -40.15% |
| 2015 Q1 | 4.83 Million USD | 154.87% |
| 2014 Q2 | 2.32 Million USD | 26.01% |
| 2014 Q3 | 1.69 Million USD | -27.26% |
| 2014 Q4 | 1.89 Million USD | 12.17% |
| 2014 FY | 7.76 Million USD | -32.92% |
| 2014 Q1 | 1.84 Million USD | -46.71% |
| 2013 Q2 | 2.42 Million USD | 4.6% |
| 2013 Q4 | 3.46 Million USD | 2.91% |
| 2013 FY | 11.57 Million USD | 9.53% |
| 2013 Q1 | 2.31 Million USD | 10.2% |
| 2013 Q3 | 3.36 Million USD | 38.88% |
| 2012 FY | 10.56 Million USD | 45.77% |
| 2012 Q3 | 1.75 Million USD | -52.26% |
| 2012 Q2 | 3.68 Million USD | 22.16% |
| 2012 Q1 | 3.01 Million USD | 2.09% |
| 2012 Q4 | 2.1 Million USD | 19.52% |
| 2011 FY | 7.24 Million USD | 85.31% |
| 2011 Q2 | 1.39 Million USD | 2.1% |
| 2011 Q3 | 1.53 Million USD | 9.9% |
| 2011 Q4 | 2.95 Million USD | 92.84% |
| 2011 Q1 | 1.36 Million USD | 6.06% |
| 2010 FY | 3.91 Million USD | 89.29% |
| 2010 Q4 | 1.28 Million USD | -0.76% |
| 2010 Q3 | 1.29 Million USD | 13.09% |
| 2010 Q1 | 178.73 Thousand USD | -57.39% |
| 2010 Q2 | 1.14 Million USD | 541.86% |
| 2009 Q1 | 539.13 Thousand USD | 0.57% |
| 2009 Q2 | 569.3 Thousand USD | 5.6% |
| 2009 Q4 | 419.42 Thousand USD | -22.08% |
| 2009 Q3 | 538.31 Thousand USD | -5.44% |
| 2009 FY | 2.06 Million USD | -1.17% |
| 2008 Q3 | 499.37 Thousand USD | 16.7% |
| 2008 Q2 | 427.91 Thousand USD | -31.79% |
| 2008 Q1 | 627.39 Thousand USD | 20.66% |
| 2008 FY | 2.09 Million USD | 7.59% |
| 2008 Q4 | 536.05 Thousand USD | 7.35% |
| 2007 Q4 | 519.97 Thousand USD | 12.56% |
| 2007 FY | 1.94 Million USD | -0.25% |
| 2007 Q1 | 453.93 Thousand USD | -4.88% |
| 2007 Q3 | 461.95 Thousand USD | -8.96% |
| 2007 Q2 | 507.41 Thousand USD | 11.78% |
| 2006 Q1 | 485.53 Thousand USD | -1.26% |
| 2006 Q3 | 574.09 Thousand USD | 39.57% |
| 2006 Q4 | 477.2 Thousand USD | -16.88% |
| 2006 FY | 1.94 Million USD | 28.64% |
| 2006 Q2 | 411.32 Thousand USD | -15.28% |
| 2005 FY | 1.51 Million USD | 32.2% |
| 2005 Q1 | 271.17 Thousand USD | -19.8% |
| 2005 Q4 | 491.73 Thousand USD | 10.16% |
| 2005 Q3 | 446.38 Thousand USD | 46.29% |
| 2005 Q2 | 305.12 Thousand USD | 12.52% |
| 2004 Q1 | 306.35 Thousand USD | -1.15% |
| 2004 Q4 | 338.1 Thousand USD | 40.93% |
| 2004 Q3 | 239.91 Thousand USD | -8.15% |
| 2004 Q2 | 261.21 Thousand USD | -14.73% |
| 2004 FY | 1.14 Million USD | 5.4% |
| 2003 Q4 | 309.92 Thousand USD | 14.23% |
| 2003 FY | 1.08 Million USD | 171.43% |
| 2003 Q3 | 271.32 Thousand USD | 4.0% |
| 2003 Q2 | 260.89 Thousand USD | 6.58% |
| 2003 Q1 | 244.78 Thousand USD | 117.55% |
| 2002 FY | 400.44 Thousand USD | 838.11% |
| 2002 Q3 | 170.42 Thousand USD | 88.84% |
| 2002 Q4 | 112.52 Thousand USD | -33.98% |
| 2002 Q2 | 90.25 Thousand USD | 231.19% |
| 2002 Q1 | 27.25 Thousand USD | 228.98% |
| 2001 Q2 | 24.11 Thousand USD | -98.02% |
| 2001 Q4 | -21.12 Thousand USD | -172.44% |
| 2001 Q3 | 29.16 Thousand USD | 20.96% |
| 2001 Q1 | 1.22 Million USD | 1403.04% |
| 2001 FY | 42.68 Thousand USD | -86.61% |
| 2000 Q3 | 73.26 Thousand USD | -43.57% |
| 2000 Q2 | 129.83 Thousand USD | 276.28% |
| 2000 Q1 | 34.5 Thousand USD | 0.0% |
| 2000 Q4 | 81.21 Thousand USD | 10.86% |
| 2000 FY | 318.81 Thousand USD | 3607.2% |
| 1999 FY | 8600.00 USD | 0.0% |